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Antimicrobial resistance among Escherichia
coli isolates from dogs presented with
urinary tract infections at a veterinary
teaching hospital in South Africa
Daniel Nenene Qekwana1, Lufuno Phophi1, Vinny Naidoo2, James Wabwire Oguttu3 and Agricola Odoi1,4*
Abstract
Background: This study investigated the burden and predictors of canine E. coli urinary tract infections (UTI) and
antimicrobial resistance among dogs presented at a veterinary teaching hospital in South Africa, 2007–2012.
Methods: The Cochran-Armitage trend test was used to investigate temporal trends while logistic regression models
were used to investigate predictors (age, sex, breed, year) of E. coli infections and antimicrobial resistance (AMR).
Results: A total of 22.3% (168/755) of the urinary specimens tested positive for E. coli. A significant (p = 0.0004)
decreasing temporal trend in the percentage of E. coli positive isolates was observed over the study period. There were
high levels of AMR to penicillin-G (99%), clindamycin (100%), tylosine (95%), cephalothin (84%) but relatively low levels
of resistance to enrofloxacin (16%), orbifloxacin (21%). Almost all (98%, 164/167) the isolates exhibited multidrug
resistance (MDR), while only 11% (19/167) and 2% (4/167) exhibited extensive drug resistance (XDR) and pan-drug
resistance (PDR), respectively.
Conclusions: Although, the risk of E. coli UTI declined during the study period, the risk of AMR increased. The high
levels of AMR and MDR as well as the presence of XDR and PDR is concerning as these have the potential of affecting
prognosis of UTI treatments.
Keywords: Antimicrobial resistance, E.coli, Urinary tract infections, Dog, Canine, Multidrug resistance, Extensive drug
resistance, Pan-drug resistance
Background
Although recent studies show that Enterococcus spp. and
Pseudomonas spp. are increasingly becoming prominent
in urinary tract infections (UTI) in dogs, Escherichia coli
remains the most common cause of UTI in dogs [1–4].
These infections are caused by uropathogenic E. coli
(UPEC), which differ from intestinal E. coli strains as they
contain extra virulence genes, allowing a successful transi-
tion from the intestinal tract to the urinary tract [5]. The
perianal and genital areas are the principal reservoirs of
the E.coli organism known to cause UTI [5]. Animals with
compromised immune systems are at higher risks of UTI
than those that are not immune-compromised. In these
animals, the organisms are able to multiply and persist in
a portion of the urinary tract resulting in clinical disease
[6, 7]. Urinary tract infections can be divided into upper
and lower tract infections. The former affects the kidneys
and ureters while the latter affects the bladder, urethra
and vagina [2, 3, 8–10]. Clinical signs of E. coli UTI in
dogs may include acute cystitis, pyelonephritis and uro-
sepsis. These three clinical signs are distinct indicators of
UTI syndromes [1].
Antimicrobial agents such amoxycillin-clavulanic acid,
tetracyclines, trimethoprim-potentiated sulphonamides
and cephalexin are reported to be effective against E. coli
UTI [11–13]. However, there are concerns of increased
antimicrobial resistance among E. coli isolates to
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fluoroquinolones in dogs with UTI [1]. Unfortunately,
there is limited information on the burden and predictors
of antimicrobial resistance (AMR), multidrug resistance
(MDR) and extensive drug resistance (XDR) among com-
panion animals in South Africa. This is despite evidence
of transfer of resistance between animals and their owners.
Therefore, the objective of this study was to investigate
the burden of E. coli infections and antimicrobial drug re-
sistance among dogs presented with UTI at a veterinary
teaching hospital in South Africa.
Methods
Data source and management
This study used retrospective data from the bacteriology
laboratory of a veterinary teaching hospital in South
Africa. Client owned dogs from Gauteng Province with
suspected UTI whose specimens were tested at the labora-
tory between January 2007 and December 2012 were in-
cluded in the study. Since this study used retrospective
laboratory records, it did not directly involve animals and
thus posed no risk to client animals. The data were
assessed for duplicates and missing information. Only
complete records were selected for inclusion in this study.
The following variables were extracted from the records:
age (in months), sex, breed and the date of specimen sub-
mission. The breed classification used in the study was
adapted from the American Kennel Club (AKC) and in-
cluded the following categories: working, sporting,
herding, hound, toy, terrier, nonsporting and mixed
breeds [14].
Escherichia coli identification and antimicrobial susceptibility
testing
Escherichia coli were isolated and identified using stand-
ard bacteriological methods and suspected E. coli colonies
were subjected to different biochemical tests as described
by Quinn et al. [15]. The E. coli reference strain (ATCC
25922) was used for quality control.
E. coli isolates were subjected to antimicrobial suscep-
tibility testing against a panel of 15 drugs using the disc
diffusion method (Kirby-Bauer method). The panel in-
cluded the following antibiotics: amikacin (30 μg), doxy-
cycline (30 μg), enrofloxacin (5 μg), gentamicin (10 μg),
ampicillin (10 μg), penicillin G (10 μg), trimethoprim-
sulphamethoxazole (co-trimoxazole) (25 μg), chloram-
phenicol (30 μg), cephalothin (30 μg), kanamycin
(30 μg), clindamycin (2 μg), lincospectin (lincomycin
hydrochloride and spectinomycin sulfate) (100 μg), orbi-
floxacin (5 μg), Synulox (amoxicillin/clavulanic acid)
(20/10 μg) and tylosin (15 μg) (Oxoid Ltd., Cambridge,
UK). To determine the susceptibility profiles of the iso-
lates, the bacteriology laboratory that processed the
specimens followed the Clinical and Laboratory
Standards Institute (CLSI) procedures for isolation,
testing and classification (2013, Clinical Institute Labora-
tory Standards 2007, Clinical Institute Laboratory
Standards 2011, Clinical Institute Laboratory Standards
2010, Clinical Institute Laboratory Standards 2012,
Clinical Institute Laboratory Standards 2008, Clinical In-
stitute Laboratory Standards 2009). Based on the labora-
tory assessments, E. coli isolates were classified as
Susceptible, Intermediate or Resistant. Isolates that ex-
hibited intermediate resistance were re-classified as re-
sistant. Multidrug resistance (MDR) was defined as
resistance to at least one agent in more than three anti-
microbial categories [16]. Extensive drug resistance
(XDR), on the other hand, was defined as resistance to
all but two of the tested antimicrobial agents in each cat-
egory while pan-drug (PDR) resistance was defined as
resistance to all antimicrobial categories tested [16].
Data analysis
Descriptive analysis
Crude and factor-specific proportions of E. coli UTI and
AMR as well as their 95% confidence intervals were
computed. The factors assessed were age, sex, breed and
year. Associations between UTI and AMR and each of
the above factors were assessed using the Chi-square or
Fishers Exact tests as appropriate. The temporal trends
in the proportions of E. coli UTI and AMR between
2007 and 2012 was assessed using Cochran–Armitage
trend tests. Significance was set at α = 0.05 for all statis-
tical tests.
Predictors of infection
The predictors of E. coli UTI were assessed using logistic
regression models. A simple binary logistic regression
was first fit to assess the association between infection
status (yes/no) and covariates age, sex, breed and year.
Predictors with a p-value less than 0.20 were considered
for inclusion in the multivariable logistic regression
model. A manual backwards elimination approach was
then used to build a multivariable logistic regression
model containing variables that had potential univariable
associations (p < 0.2) with the outcome. At this stage sig-
nificance was set at α = 0.05. To assess for confounding,
the changes in parameter estimates of the predictors in
the model with and without the suspected confounding
variable were compared. Changes of 20% in the esti-
mates were considered indicative of significant con-
founding and hence the suspected confounding variables
were retained in the final model. Adjusted odds ratios
and 95% confidence intervals were calculated for all pre-
dictors retained in the final model. Statistical significance
was assessed using Wald Chi-Squared Test at α = 0.05.
Hosmer-Lemeshow test was used to assess goodness-of-fit
of the final model.
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Results
Descriptive analysis
The median age of dogs tested was 72 months
(Interquartile range: 32–116). More males (58%) than fe-
males (42%) were tested (Table 1). The working breeds
constituted the highest proportion (24%) of dogs tested
followed by the hound (14%), herding (13%) and sport-
ing (13%) breeds. The highest proportion (23%) of speci-
mens was tested in 2010, followed by 2007 and 2009
each with 20% specimens tested (Table 1).
Risks of Escherichia coli UTI
Twenty two percent (22%; n = 168/755) of the urinary
specimens tested positive for E. coli. Based on simple as-
sociation assessments, there was no significant associ-
ation between risk of E. coli UTI and breed (p = 0.283).
On the other hand, there was a significant association
between risk of E. coli UTI and both year (p < 0.001)
and sex (p = 0.054) (Table 2).
Antimicrobial resistance
The majority of E. coli isolates were resistant to
penicillin-G (99.4%), clindamycin (100%), tylosine (95.0%),
cephalothin (84%), amoxycillin-ampicillin (70%), doxycyc-
line (68%) and lincospectin (63%). However, low levels of
resistance were observed against enrofloxacin (16%),
orbifloxacin (21%), trimethoprim-sulphamethoxazole (25%)
and chloramphenicol (25%) (Table 3).
Resistance to Lincosamides (100%), Lincospectin
(100%), Macrolide (95%), Cephalosporin (84%), Penicillin
(70%), Tetracycline (68%) was very high. On the con-
trary, much lower resistance levels were observed against
Amphenicol (25%), Aminoglycoside (22%) and Fluoro-
quinolone (13%) (Table 4). With regard to multiple re-
sistance, almost all E. coli isolates that were AMR
exhibited MDR (98%, 164/167), while 11% (19/167) were
XDR and only 2% (4/167) were PDR.
Predictors of Escherichia coli infection and antimicrobial
resistance
Based on the multivariable logistic model, age (p = 0.465),
sex (p = 0.318) and breed (p = 0.300) all showed no evi-
dence of significant association with odds of E. coli UTI.
However, there was a significant association between the
odds of E. coli UTI and time (years) with the odds of in-
fection significantly (p < 0.001) decreasing (OR = 0.78,
95% CI: 0.68–0.89) during the study period.
None of the variables assessed: age (p = 0.972), sex
(p = 0.282), breed (p = 0.309) and year (p = 0.394) had a
significant association with the odds of multi-drug resist-
ance among E. coli isolates.
Table 1 Profile of all specimens tested for Escherichia coli
urinary tract infections at the bacteriology laboratory of a





Sex (n = 676)
Female 393 58.1
Male 283 41.9
















Table 2 Distribution of the proportion Escherichia coli Urinary
Tract Infections by sex, breed and time among dogs admitted









Female 393 80 20.36 0.054
Male 283 50 17.67
Breed
Working 162 43 26.54 0.283
Hound 97 16 16.49
Herding 89 17 19.1
Sporting 87 17 19.54
Terrier 85 17 20
Toy 80 10 12.5
Nonsporting 45 7 15.56
Crossbreed 32 6 18.75
Year
2007 137 39 28.47 <0.001
2008 110 27 24.55
2009 137 19 13.87
2010 156 29 18.59
2011 97 19 19.59
2012 46 0 0
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Discussion
In this study, we investigated the burden and predictors
of E. coli UTI and their antimicrobial resistance patterns
from dogs presented at a veterinary teaching hospital in
South Africa. The results of this study will support man-
agement and treatment of UTIs in dogs presented at the
veterinary hospital.
In this study, we observed a lower proportion of E. coli
positive samples (22%) than the 27% reported by Stiffler et
al. [17], 56% reported by Seguin et al. [13], 44% reported
by Johnson et al. [2] in the USA and 62% reported by
Gibson et al. [1] in Australia. The differences in the results
may be due to differences in study designs. The studies by
Stiffler et al. [17] and Seguin et al. [13] were longitudinal
studies investigating risk before hospitalization and after
surgery, while our study investigated E. coli UTI among
hospitalized dogs in a veterinary teaching hospital. It is
also possible that the presence of underlying disorders in
the study by Stiffler et al. [17] and Seguin et al. [13], which
our study did not investigate, could explain the differences
in the proportions of E. coli positive samples. Dogs with
underlying medical conditions such as diabetes mellitus,
hyper-adrenocorticism and pre-existing urinary tract dis-
eases have a weaker immune system making them prone
to E. coli infections [13].
Thompson et al. [4] reported an increase in the preva-
lence of UTI in dogs over the period of their study. How-
ever, in our study, we observed a decrease in the
proportion of E. coli positive samples. This could be due to
improved health and welfare of the dogs visiting the
hospital.
The results of this study show that age, breed and sex
were not significantly associated with the odds of E. coli
UTI among dogs presented at the hospital in South
Africa. This is consistent with findings by Stiffler et al.
[17] who reported no significant association between E.
coli UTI and age, breed or weight of the dog. However,
Stiffler et al. [17] reported that female dogs were 3 times
more likely to contract E. coli related UTI compared to
male dogs. By contrast, Johnson et al. [2] observed that
the risk of E. coli UTI was higher in males compared to
female dogs. These findings suggest that there may be
sex predisposition for E. coli related UTI although our
study did not identify such a relationship. Sex related
risk of E. coli UTI has been shown to be related to the
differences in the anatomic structure between male and
female dogs. This makes manually expressing of female
bladder easier for urine sample collection than intermit-
tent catheterization needed in male dogs [17]. Moreover,
indwelling urinary catheters during diuresis or adminis-
tration of corticosteroid are also major risk factors of
UTI in dogs. These may be due to conformational
changes, altered normal flora, or decreased immune re-
sponse [7, 17, 18]. Contrary to the findings of our study,
Stiffler et al. [17] reported that dogs ≤3 years were more
likely to present with UTI compared to dogs > 3 years.
While resistance to penicillin-G, clindamycin, tylo-
sin, cephalothin, amoxycillin, ampicillin, doxycycline
and lincospectin were common in the majority of the
E. coli isolates in this study, a study in Sweden re-
ported low levels of resistance to ampicillin (17%),
and tetracycline (7%) among E. coli UTI [12]. The
reason for the higher resistance levels observed in
this study is unclear and requires further investiga-
tion. However, low levels of resistance to
Table 3 Antimicrobial resistance patterns of Escherichia coli
from urine specimens of clinical cases of dogs admitted to a







Penicillin G 164 163 99.4
Clindamycin 160 160 100
Tylosine 161 153 95.0
Cephalothin 166 139 83.7
Amoxycillin 164 115 70.1
Doxycycline 166 112 67.5
Lincospectin 164 104 63.4
Synulox 163 95 58.3
Kanamycin 163 91 55.8
Amikacin 166 61 36.8
Gentamicin 166 47 28.3
Trimethoprim-Sulphamethoxazole 166 41 24.7
Orbifloxacin 162 34 21.0
Chloramphenicol 118 29 24.6
Enrofloxacin 167 27 16.2
Table 4 Antimicrobial resistance of Escherichia coli isolates from
urine specimens of canine clinical cases admitted to the







Lincosamides 160 160 100
Lincospectin 104 104 100
Macrolides 161 153 95.0
Cephalosporins 166 139 83.7
Penicillins 167 117 70.1
Tetracyclines 166 112 67.5
Synulox 163 95 58.3
Potentiated sulpha 166 41 24.7
Amphenicols 118 29 24.6
Aminoglycoside 167 36 21.6
Fluoroquinolone 167 21 12.6
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fluoroquinolones, sulpha trimethoprim and chloram-
phenicol observed in our study are similar to the
findings of other studies [11, 13, 19].
Although our findings are contrary to those of Wedley
et al. [20] who observed a low proportion (18%) of E. coli
that were MDR-among dogs with urinary tract infec-
tions, the high proportion of MDR (98%) in our study is
not unusual. For example, Gibson et al. [1] and Wagner
et al. [21] also observed high proportions of MDR
among E.coli isolates from dogs with UTIs. This ob-
servation has serious implications for clinical out-
comes during treatment given that multiple drug
resistance has a negative effect on the prognosis of E.
coli UTI in veterinary medicine [22–24]. Of even
greater concern among the findings of the present
study is the presence of XDR (11%) and PDR (2%) E.
coli isolates. The proportion of XDR isolates observed
in this study is higher than the 2% reported by Thun-
grat et al. [25] in the USA. Furthermore, the ability
of E. coli isolates to transfer resistance genes among
themselves and other species of bacteria [26], makes
the levels of XDR and PDR observed in this study of
great veterinary public health concern.
In the present study, no previous history of antimicro-
bial usage among the dogs tested was available. Moreover,
some cases might have been treated empirically prior to
culture and susceptibility testing. In addition, isolates that
exhibited intermediate resistance in this study were
re-classified as resistant. Therefore, it is possible that this
could have slightly biased the findings towards higher esti-
mates of resistance levels among the E. coli isolates ob-
served in this study. Nonetheless, the results of this study
support previous studies that showed that E. coli is a com-
mon cause of UTI in dogs and contributes to the under-
standing of antimicrobial resistance patterns among E. coli
UTI in the dog population presented at the veterinary
teaching hospital in South Africa.
Conclusions
This study shows that the proportion of cases of E. coli
UTI among dogs presented at the veterinary teaching
hospital declined over the study period. However, high
levels of E. coli isolates exhibiting MDR, XDR and PDR
are of clinical and a veterinary public health concern.
Therefore, urgent action needs to be taken to tackle the
development of antimicrobial drug resistant E. coli infec-
tions in dogs. This may require development of
antimicrobial stewardship programme at the teaching
hospital and in the country.
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